{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:53:54Z","timestamp":1774076034277,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cytogfr.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T17:30:45Z","timestamp":1588786245000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Begum","family":"Dariya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganji Purnachandra","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0005","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Novel","year":"2020","journal-title":"Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi"},{"issue":"8","key":"10.1016\/j.cytogfr.2020.05.001_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10223","key":"10.1016\/j.cytogfr.2020.05.001_bib0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-012362675-2\/50004-5","article-title":"Virus morphology, replication, and assembly","author":"NAYAK","year":"2000","journal-title":"Viral Ecology"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.05.001_bib0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.cytogfr.2020.05.001_bib0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","article-title":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme","volume":"532","author":"Harmer","year":"2002","journal-title":"FEBS Lett."},{"issue":"7798","key":"10.1016\/j.cytogfr.2020.05.001_bib0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0040","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Ziebuhr","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jmb.2005.09.004","article-title":"Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide","volume":"353","author":"Lee","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0065","first-page":"1","article-title":"The neuroinvasive potential of SARS\u2010CoV2 may be at least partially responsible for the respiratory failure of COVID\u201019 patients","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0070","article-title":"Identification of a pangolin niche for a 2019-nCoV-like coronavirus through an extensive meta-metagenomic search","author":"Wahba","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/896861","article-title":"The ACE2\/apelin signaling, microRNAs, and hypertension","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"issue":"20","key":"10.1016\/j.cytogfr.2020.05.001_bib0085","first-page":"30079","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"S2213-2600","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS\u2010CoV\u20102 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID\u201019","author":"Gao","year":"2020","journal-title":"J. Med. Virol."},{"issue":"10229","key":"10.1016\/j.cytogfr.2020.05.001_bib0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0105","article-title":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","author":"Wan","year":"2020","journal-title":"Medrxiv"},{"issue":"5","key":"10.1016\/j.cytogfr.2020.05.001_bib0110","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ajic.2015.11.018","volume":"44","author":"Weber","year":"2016","journal-title":"Am. J. Infect. Control"},{"issue":"7","key":"10.1016\/j.cytogfr.2020.05.001_bib0115","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.watres.2009.02.002","article-title":"Survival of surrogate coronaviruses in water","volume":"43","author":"Casanova","year":"2009","journal-title":"Water Res."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0120","article-title":"Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis","author":"Sardar","year":"2020","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.cytogfr.2020.05.001_bib0125","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/JVI.05065-11","article-title":"Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes","volume":"86","author":"Chiang","year":"2012","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.05.001_bib0130","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00705-018-3847-1","article-title":"Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2018)","volume":"163","author":"King","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25827","article-title":"The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID\u201019): well\u2010mixed SEIR model analysis","author":"Hou","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0140","article-title":"Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China","author":"Lam","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0145","article-title":"Isolation and characterization of 2019-nCoV-like coronavirus from Malayan pangolins","author":"Xiao","year":"2020","journal-title":"BioRxiv"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0150","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland"},{"issue":"6891","key":"10.1016\/j.cytogfr.2020.05.001_bib0155","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cytogfr.2020.05.001_bib0160","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1096\/fj.08-107300","article-title":"A protein complex in the brush-border membrane explains a Hartnup disorder allele","volume":"22","author":"Kowalczuk","year":"2008","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.05.001_bib0165","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme\u2013related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.cytogfr.2020.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2020.05.001_bib0180","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0185","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","article-title":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","volume":"67","author":"Chu","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-020-0366-2","article-title":"COVID-19 and cancer: what we know so far","author":"Sidaway","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0200","article-title":"Influenza vaccines in immunosuppressed adults with cancer","author":"Bitterman","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"20","key":"10.1016\/j.cytogfr.2020.05.001_bib0205","first-page":"36383","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"S0923-7534","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4683","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","author":"Onder","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0215","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0220","first-page":"615","article-title":"The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic","author":"Bitar","year":"2020","journal-title":"Future Medicine"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0225","series-title":"Prevention, National Diabetes Statistics Report, 2020","first-page":"1","author":"CF.D. Control","year":"2020"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"10229","key":"10.1016\/j.cytogfr.2020.05.001_bib0235","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.05.001_bib0240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cytogfr.2020.05.001_bib0245","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.cytogfr.2020.05.001_bib0250","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cytogfr.2020.05.001_bib0255","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1210\/en.2014-1685","article-title":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats","volume":"156","author":"Roman\u00ed-P\u00e9rez","year":"2015","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.05.001_bib0260","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bcp.2014.11.013","article-title":"Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications","volume":"93","author":"Tikoo","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0265","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute respiratory distress syndrome leads to reduced ratio of ACE\/ACE2 activities and is prevented by angiotensin\u2010(1\u20137) or an angiotensin II receptor antagonist","volume":"225","author":"W\u00f6sten\u2010van Asperen","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0270","article-title":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis","volume":"2014","author":"Zhang","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0275","article-title":"Exploring diseases\/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: a Mendelian Randomization analysis","author":"Rao","year":"2020","journal-title":"medRxiv"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0280","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/joim.12783","article-title":"Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality","volume":"284","author":"Fernandez","year":"2018","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.cytogfr.2020.05.001_bib0285","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1097\/PCC.0b013e3182a55735","article-title":"Imbalance between pulmonary angiotensin-converting enzyme and angiotensin-converting enzyme 2 activity in acute respiratory distress syndrome","volume":"14","author":"W\u00f6sten-van Asperen","year":"2013","journal-title":"Pediatr. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.05.001_bib0290","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.05.001_bib0295","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV","volume":"21","author":"Liu","year":"2020","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0305","first-page":"1","article-title":"Old weapon for new enemy: drug repurposing for treatment of newly emerging viral diseases","author":"Guo","year":"2020","journal-title":"Virol. Sin."},{"issue":"7795","key":"10.1016\/j.cytogfr.2020.05.001_bib0310","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/d41586-020-00444-3","article-title":"More than 80 clinical trials launch to test coronavirus treatments","volume":"578","author":"Maxmen","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.05.001_bib0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0325","unstructured":"M. Bulloch, Potential Pipeline Medications May Help Patients With Novel Coronavirus, pharmacytimes."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0330","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004717","article-title":"The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases","volume":"11","author":"Casadevall","year":"2015","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.cytogfr.2020.05.001_bib0345","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.cytogfr.2020.05.001_bib0350","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1074\/jbc.M111.325803","article-title":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-018-0082-4","article-title":"Generation of therapeutic antisera for emerging viral infections","volume":"3","author":"Schmidt","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0360","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-7091-7482-1_12","article-title":"Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses","author":"Jahrling","year":"1996","journal-title":"Imported Virus Infections, Springer"},{"issue":"24","key":"10.1016\/j.cytogfr.2020.05.001_bib0365","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"issue":"43","key":"10.1016\/j.cytogfr.2020.05.001_bib0370","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cytogfr.2020.05.001_bib0380","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.cytogfr.2020.05.001_bib0390","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE 2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yjmcc.2016.05.012","article-title":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang (1\u20137)-Mas axes in pressure overload-induced cardiac remodeling in male mice","volume":"97","author":"Wang","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0400","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0405","doi-asserted-by":"crossref","first-page":"F487","DOI":"10.1152\/ajprenal.00074.2017","article-title":"Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease","volume":"313","author":"Wysocki","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"2","key":"10.1016\/j.cytogfr.2020.05.001_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and nonclassic renin-angiotensin systems in the critically ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0415","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS\u2010CoV\u20102 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"7047","key":"10.1016\/j.cytogfr.2020.05.001_bib0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2020.05.001_bib0425","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.cytogfr.2020.05.001_bib0430","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0440","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25761","article-title":"The potential chemical structure of anti\u2010SARS\u2010CoV\u20102 RNA\u2010dependent RNA polymerase","author":"Lung","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0445","first-page":"E1","article-title":"Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches","volume":"307","author":"Zhavoronkov","year":"2020","journal-title":"Insilico Medicine Hong Kong Ltd A"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0455","first-page":"10","article-title":"Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)","volume":"38","author":"Shanmugaraj","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2020.05.001_bib0460","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today\u2019s diseases","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0465","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0470","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cytogfr.2020.05.001_bib0475","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.cytogfr.2020.05.001_bib0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610120300782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610120300782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:56:16Z","timestamp":1761216976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610120300782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":96,"alternative-id":["S1359610120300782"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}